Taltz (ixekizumab)

pCPA File Number: 21192
Negotiation Status:
Concluded without agreement
Indication(s):
Ankylosing spondylitis
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
SR0630-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: